Major CHI Lab projects focus on the development of AI-based systems to exploit rich clinical datasets, with the goal of improving the understand and treatment of complex diseases.  The Oxford University Hospitals and wider collaborations provide very great opportunities to develop new AI methods for diseases that often include both genomic and clinical data.

We have large on-going EPSRC- and Wellcome-funded activity in cardiovascular disease and ECG analysis; chronic obstructive pulmonary disease (COPD, or lung disease); epidemiology via the UK Biobank and China Kadoorie Biobank; and immune disease.  All of these projects are characterised by the needs of complex methods to link the very many different types of data that are typically available for each disease.